• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动患者登记处和临床实践中使用的协调结局指标:得到心律学会理事会的认可。

Harmonized outcome measures for use in atrial fibrillation patient registries and clinical practice: Endorsed by the Heart Rhythm Society Board of Trustees.

机构信息

Cardiology Division, Johns Hopkins University, Baltimore, Maryland.

OM1, Inc., Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

出版信息

Heart Rhythm. 2019 Jan;16(1):e3-e16. doi: 10.1016/j.hrthm.2018.09.021. Epub 2018 Nov 16.

DOI:10.1016/j.hrthm.2018.09.021
PMID:30449519
Abstract

BACKGROUND

Atrial fibrillation (AF) affects an estimated 33 million people worldwide, leading to increased mortality and an increased risk of heart failure and stroke. Many AF patient registries exist, but the ability to link and compare data across registries is hindered by differences in the outcome measures collected by each registry and a lack of harmonization.

OBJECTIVES

The purpose of this project was to develop a minimum set of standardized outcome measures that could be collected in AF patient registries and clinical practice.

METHODS

AF patient registries were identified through multiple sources and invited to join the workgroup and submit outcome measures. Additional measures were identified through literature searches and reviews of consensus statements. Outcome measures were categorized using the Agency for Healthcare Research and Quality's supported Outcome Measures Framework (OMF). A minimum set of broadly relevant measures was identified. Measure definitions were harmonized through in-person and virtual meetings.

RESULTS

One hundred twelve outcome measures, including those from thirteen registries, were curated according to the OMF and then harmonized into a minimum set of measures in the OMF categories of survival (3 measures), clinical response (3 measures), events of interest (9 measures), patient-reported outcomes (2 measures), and resource utilization (3 measures). The harmonized definitions build on existing consensus statements.

CONCLUSIONS

The harmonized measures represent a minimum set of outcomes that are relevant in AF research and clinical practice. Routine and consistent collection of these measures in registries and in other systems would support creation of a research infrastructure to efficiently address new questions and improve patient outcomes.

摘要

背景

心房颤动(AF)影响全球约 3300 万人,导致死亡率增加,心力衰竭和中风风险增加。存在许多 AF 患者登记处,但由于每个登记处收集的结果衡量标准存在差异以及缺乏协调,因此难以在登记处之间进行链接和比较数据。

目的

本项目旨在制定一套标准化的最小结果衡量标准,可在 AF 患者登记处和临床实践中收集。

方法

通过多种来源确定 AF 患者登记处,并邀请他们加入工作组并提交结果衡量标准。通过文献检索和共识声明的审查,确定了其他措施。使用美国医疗保健研究与质量局(Agency for Healthcare Research and Quality)支持的结果衡量标准框架(OMF)对结果衡量标准进行分类。确定了一组最小但广泛相关的措施。通过面对面和虚拟会议协调衡量标准的定义。

结果

根据 OMF 对 112 种结果衡量标准进行了策展,其中包括来自 13 个登记处的衡量标准,然后将其协调为 OMF 类别中生存(3 个衡量标准)、临床反应(3 个衡量标准)、关注事件(9 个衡量标准)、患者报告的结果(2 个衡量标准)和资源利用(3 个衡量标准)中的一组最小措施。协调后的定义建立在现有共识声明的基础上。

结论

协调后的措施代表了在 AF 研究和临床实践中相关的最小结果集。在登记处和其他系统中常规且一致地收集这些措施将支持创建一个研究基础设施,以有效地解决新问题并改善患者的结果。

相似文献

1
Harmonized outcome measures for use in atrial fibrillation patient registries and clinical practice: Endorsed by the Heart Rhythm Society Board of Trustees.心房颤动患者登记处和临床实践中使用的协调结局指标:得到心律学会理事会的认可。
Heart Rhythm. 2019 Jan;16(1):e3-e16. doi: 10.1016/j.hrthm.2018.09.021. Epub 2018 Nov 16.
2
Harmonized outcome measures for use in asthma patient registries and clinical practice.哮喘患者登记和临床实践中使用的协调结局指标。
J Allergy Clin Immunol. 2019 Sep;144(3):671-681.e1. doi: 10.1016/j.jaci.2019.02.025. Epub 2019 Mar 9.
3
Harmonized Outcome Measures for Use in Depression Patient Registries and Clinical Practice.用于抑郁患者注册和临床实践的协调结局测量。
Ann Intern Med. 2020 Jun 16;172(12):803-809. doi: 10.7326/M19-3818. Epub 2020 May 12.
4
Harmonized Outcome Measures for Use in Non-Small Cell Lung Cancer Patient Registries and Clinical Practice.用于非小细胞肺癌患者登记和临床实践的统一结局指标
J Natl Compr Canc Netw. 2021 Aug 13. doi: 10.6004/jnccn.2021.7021.
5
Harmonized outcome measures for use in degenerative lumbar spondylolisthesis patient registries and clinical practice.用于退行性腰椎滑脱患者登记和临床实践的统一结局指标。
J Neurosurg Spine. 2021 Mar 19;34(6):888-896. doi: 10.3171/2020.9.SPINE20437. Print 2021 Jun 1.
6
One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.不同临床环境下房颤患者的卒中与死亡 1 年风险:海湾 SAFE 登记研究和达灵顿房颤登记研究。
Int J Cardiol. 2019 Jan 1;274:158-162. doi: 10.1016/j.ijcard.2018.08.091. Epub 2018 Sep 1.
7
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).心房颤动对心力衰竭患者死亡率、卒中风险及生活质量评分的影响(源自心房颤动更优治疗结局注册研究[ORBIT-AF])
Am J Cardiol. 2017 Jun 1;119(11):1763-1769. doi: 10.1016/j.amjcard.2017.02.050. Epub 2017 Mar 16.
8
Clinical presentation, management, and outcomes in the Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF) registry.印度心律学会心房颤动(IHRS-AF)注册研究中的临床表现、管理及结果
Indian Heart J. 2017 Jan-Feb;69(1):43-47. doi: 10.1016/j.ihj.2016.06.006. Epub 2016 Jun 29.
9
Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).在房颤患者中心脏瓣膜病的流行情况、特征和结局:来自 ORBIT-AF(房颤更好治疗信息登记结果)的见解。
J Am Heart Assoc. 2017 Dec 22;6(12):e006475. doi: 10.1161/JAHA.117.006475.
10
Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry.醛固酮受体拮抗剂在心房颤动患者中的应用:来自 ORBIT-AF(房颤更明智治疗的结局登记研究)登记研究的结果。
J Am Heart Assoc. 2018 Apr 13;7(8):e007987. doi: 10.1161/JAHA.117.007987.

引用本文的文献

1
Outcomes of atrial fibrillation ablation in community hospitals with and without onsite cardiothoracic surgery availability.有和没有现场心胸外科手术条件的社区医院中房颤消融的结果。
J Interv Card Electrophysiol. 2024 Sep 26. doi: 10.1007/s10840-024-01920-w.
2
Development of ore utcome ets for trials on the management of trial firilltion in ritically nwell patient (COS-ABACUS): a protocol.用于管理危重病患者试验性房颤的试验结局指标的制定(COS-ABACUS):方案。
BMJ Open. 2023 Apr 29;13(4):e067257. doi: 10.1136/bmjopen-2022-067257.
3
Development of a Bariatric Surgery Core Data Set for an International Registry.
国际注册研究用减重手术核心数据集的建立。
Obes Surg. 2023 May;33(5):1463-1475. doi: 10.1007/s11695-023-06545-y. Epub 2023 Mar 24.
4
Sex-Related Differences in Clinical Outcomes in Patients with Atrial Fibrillation and Coronary Artery Disease: A Sub-Study of the MISOAC-AF Randomized Controlled Trial.心房颤动合并冠状动脉疾病患者临床结局的性别差异:MISOAC-AF随机对照试验的一项子研究
J Clin Med. 2022 Oct 1;11(19):5843. doi: 10.3390/jcm11195843.
5
Institutional Variation in 30-Day Complications Following Catheter Ablation of Atrial Fibrillation.房颤导管消融术后 30 天内并发症的机构差异。
J Am Heart Assoc. 2022 Feb 15;11(4):e022009. doi: 10.1161/JAHA.121.022009. Epub 2022 Feb 12.
6
Harmonized Outcome Measures for Use in Non-Small Cell Lung Cancer Patient Registries and Clinical Practice.用于非小细胞肺癌患者登记和临床实践的统一结局指标
J Natl Compr Canc Netw. 2021 Aug 13. doi: 10.6004/jnccn.2021.7021.
7
A prospective multi-site registry of real-world experience of catheter ablation for treatment of symptomatic paroxysmal and persistent atrial fibrillation (Real-AF): design and objectives.一项针对症状性阵发性和持续性心房颤动导管消融治疗的真实世界经验的前瞻性多中心注册研究(Real-AF):设计和目标。
J Interv Card Electrophysiol. 2021 Dec;62(3):487-494. doi: 10.1007/s10840-021-01031-w. Epub 2021 Jul 2.
8
Patient-reported outcomes and the identification of subgroups of atrial fibrillation patients: a retrospective cohort study of linked clinical registry and administrative data.患者报告结局和心房颤动患者亚组的识别:基于临床注册和行政数据的回顾性队列研究。
Qual Life Res. 2021 Jun;30(6):1547-1559. doi: 10.1007/s11136-021-02777-6. Epub 2021 Feb 12.
9
Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management.新型监测设备与机器学习技术的融合,实现可扩展的心血管管理。
Nat Rev Cardiol. 2021 Feb;18(2):75-91. doi: 10.1038/s41569-020-00445-9. Epub 2020 Oct 9.
10
Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group.制定国际通用的房颤患者结局测评标准集:国际卫生结局测量合作组织(ICHOM)房颤工作组报告。
Eur Heart J. 2020 Mar 7;41(10):1132-1140. doi: 10.1093/eurheartj/ehz871.